Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]E. S. Lander, L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, Y. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, R. A. Gibbs, D. M. Muzny, S. E. Scherer, J. B. Bouck, E. J. Sodergren, K. C. Worley, C. M. Rives, J. H. Gorrell, M. L. Metzker, S. L. Naylor, R. S. Kucherlapati, D. L. Nelson, G. M. Weinstock, Y. Sakaki, A. Fujiyama, M. Hattori, T. Yada, A. Toyoda, T. Itoh, C. Kawagoe, H. Watanabe, Y. Totoki, T. Taylor, J. Weissenbach, R. Heilig, W. Saurin, F. Artiguenave, P. Brottier, T. Bruls, E. Pelletier, C. Robert, P. Wincker, D. R. Smith, L. Doucette-Stamm, M. Rubenfield, K. Weinstock, H. M. Lee, J. Dubois, A. Rosenthal, M. Platzer, G. Nyakatura, S. Taudien, A. Rump, H. Yang, J. Yu, J. Wang, G. Huang, J. Gu, L. Hood, L. Rowen, A. Madan, S. Qin, R. W. Davis, N. A. Federspiel, A. P. Abola, M. J. Proctor, R. M. Myers, J. Schmutz, M. Dickson, J. Grimwood, D. R. Cox, M. V. Olson, R. Kaul, C. Raymond, N. Shimizu, K. Kawasaki, S. Minoshima, G. A. Evans, M. Athanasiou, R. Schultz, B. A. Roe, F. Chen, H. Pan, J. Ramser, H. Lehrach, R. Reinhardt, W. R. McCombie, M. de la Bastide, N. Dedhia, H. Blocker, K. Hornischer, G. Nordsiek, R. Agarwala, L. Aravind, J. A. Bailey, A. Bateman, S. Batzoglou, E. Birney, P. Bork, D. G. Brown, C. B. Burge, L. Cerutti, H. C. Chen, D. Church, M. Clamp, R. R. Copley, T. Doerks, S. R. Eddy, E. E. Eichler, T. S. Furey, J. Galagan, J. G. Gilbert, C. Harmon, Y. Hayashizaki, D. Haussler, H. Hermjakob, K. Hokamp, W. Jang, L. S. Johnson, T. A. Jones, S. Kasif, A. Kaspryzk, S. Kennedy, W. J. Kent, P. Kitts, E. V. Koonin, I. Korf, D. Kulp, D. Lancet, T. M. Lowe, A. McLysaght, T. Mikkelsen, J. V. Moran, N. Mulder, V. J. Pollara, C. P. Ponting, G. Schuler, J. Schultz, G. Slater, A. F. Smit, E. Stupka, J. Szustakowki, D. Thierry-Mieg, J. Thierry-Mieg, L. Wagner, J. Wallis, R. Wheeler, A. Williams, Y. I. Wolf, K. H. Wolfe, S. P. Yang, R. F. Yeh, F. Collins, M. S. Guyer, J. Peterson, A. Felsenfeld, K. A. Wetterstrand, A. Patrinos, M. J. Morgan, P. de Jong, J. J. Catanese, K. Osoegawa, H. Shizuya, S. Choi, Y. J. Chen, J. Szustakowki and C. International Human Genome Sequencing: Initial sequencing and analysis of the human genome. Nature, 409(6822), 860-921 (2001)

  • [2]E. P. Consortium: An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414), 57-74 (2012)

  • [3]S. Djebali, C. A. Davis, A. Merkel, A. Dobin, T. Lassmann, A. Mortazavi, A. Tanzer, J. Lagarde, W. Lin, F. Schlesinger, C. Xue, G. K. Marinov, J. Khatun, B. A. Williams, C. Zaleski, J. Rozowsky, M. Roder, F. Kokocinski, R. F. Abdelhamid, T. Alioto, I. Antoshechkin, M. T. Baer, N. S. Bar, P. Batut, K. Bell, I. Bell, S. Chakrabortty, X. Chen, J. Chrast, J. Curado, T. Derrien, J. Drenkow, E. Dumais, J. Dumais, R. Duttagupta, E. Falconnet, M. Fastuca, K. Fejes-Toth, P. Ferreira, S. Foissac, M. J. Fullwood, H. Gao, D. Gonzalez, A. Gordon, H. Gunawardena, C. Howald, S. Jha, R. Johnson, P. Kapranov, B. King, C. Kingswood, O. J. Luo, E. Park, K. Persaud, J. B. Preall, P. Ribeca, B. Risk, D. Robyr, M. Sammeth, L. Schaffer, L. H. See, A. Shahab, J. Skancke, A. M. Suzuki, H. Takahashi, H. Tilgner, D. Trout, N. Walters, H. Wang, J. Wrobel, Y. Yu, X. Ruan, Y. Hayashizaki, J. Harrow, M. Gerstein, T. Hubbard, A. Reymond, S. E. Antonarakis, G. Hannon, M. C. Giddings, Y. Ruan, B. Wold, P. Carninci, R. Guigo and T. R. Gingeras: Landscape of transcription in human cells. Nature, 489(7414), 101-8 (2012)

  • [4]F. Crick: Central dogma of molecular biology. Nature, 227(5258), 561-3 (1970)

  • [5]J. R. Ecker, W. A. Bickmore, I. Barroso, J. K. Pritchard, Y. Gilad and E. Segal: Genomics: ENCODE explained. Nature, 489(7414), 52-5 (2012)

  • [6]F. F. Costa: Non-coding RNAs: could they be the answer? Brief Funct Genomics, 10(5), 316-9 (2011)

  • [7]K. Numata and H. Kiyosawa: Genome-wide impact of endogenous antisense transcripts in eukaryotes. Front Biosci (Landmark Ed), 17, 300-15 (2012)

  • [8]C. H. Li and Y. Chen: Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol, 45(8), 1895-910 (2013)

  • [9]W. Y. Su, J. T. Li, Y. Cui, J. Hong, W. Du, Y. C. Wang, Y. W. Lin, H. Xiong, J. L. Wang, X. Kong, Q. Y. Gao, L. P. Wei and J. Y. Fang: Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer. Cell Res, 22(9), 1374-89 (2012)

  • [10]P. Johnsson, A. Ackley, L. Vidarsdottir, W. O. Lui, M. Corcoran, D. Grander and K. V. Morris: A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol, 20(4), 440-6 (2013)

  • [11]T. Gutschner and S. Diederichs: The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol, 9(6), 703-19 (2012)

  • [12]M. Nishizawa, Y. Ikeya, T. Okumura and T. Kimura: Post-transcriptional inducible gene regulation by natural antisense RNA. Front Biosci (Landmark Ed), 20, 1-36 (2015)

  • [13]M. Nishizawa, T. Okumura, Y. Ikeya and T. Kimura: Regulation of inducible gene expression by natural antisense transcripts. Front Biosci (Landmark Ed), 17, 938-58 (2012)

  • [14]J. H. Luo, B. Ren, S. Keryanov, G. C. Tseng, U. N. Rao, S. P. Monga, S. Strom, A. J. Demetris, M. Nalesnik, Y. P. Yu, S. Ranganathan and G. K. Michalopoulos: Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology, 44(4), 1012-24 (2006)

  • [15]M. Huarte, M. Guttman, D. Feldser, M. Garber, M. J. Koziol, D. Kenzelmann-Broz, A. M. Khalil, O. Zuk, I. Amit, M. Rabani, L. D. Attardi, A. Regev, E. S. Lander, T. Jacks and J. L. Rinn: A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell, 142(3), 409-19 (2010)

  • [16]Y. J. Geng, S. L. Xie, Q. Li, J. Ma and G. Y. Wang: Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res, 39(6), 2119-28 (2011)

  • [17]R. Kogo, T. Shimamura, K. Mimori, K. Kawahara, S. Imoto, T. Sudo, F. Tanaka, K. Shibata, A. Suzuki, S. Komune, S. Miyano and M. Mori: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res, 71(20), 6320-6 (2011)

  • [18]J. R. Prensner, M. K. Iyer, O. A. Balbin, S. M. Dhanasekaran, Q. Cao, J. C. Brenner, B. Laxman, I. A. Asangani, C. S. Grasso, H. D. Kominsky, X. Cao, X. Jing, X. Wang, J. Siddiqui, J. T. Wei, D. Robinson, H. K. Iyer, N. Palanisamy, C. A. Maher and A. M. Chinnaiyan: Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol, 29(8), 742-9 (2011)

  • [19]L. H. Schmidt, T. Spieker, S. Koschmieder, S. Schaffers, J. Humberg, D. Jungen, E. Bulk, A. Hascher, D. Wittmer, A. Marra, L. Hillejan, K. Wiebe, W. E. Berdel, R. Wiewrodt and C. Muller-Tidow: The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol, 6(12), 1984-92 (2011)

  • [20]J. M. Silva, N. J. Boczek, M. W. Berres, X. Ma and D. I. Smith: LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol, 8(3), 496-505 (2011)

  • [21]T. Niinuma, H. Suzuki, M. Nojima, K. Nosho, H. Yamamoto, H. Takamaru, E. Yamamoto, R. Maruyama, T. Nobuoka, Y. Miyazaki, T. Nishida, T. Bamba, T. Kanda, Y. Ajioka, T. Taguchi, S. Okahara, H. Takahashi, Y. Nishida, M. Hosokawa, T. Hasegawa, T. Tokino, K. Hirata, K. Imai, M. Toyota and Y. Shinomura: Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res, 72(5), 1126-36 (2012)

  • [22]Y. Han, Y. Liu, Y. Gui and Z. Cai: Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol, 107(5), 555-9 (2013)

  • [23]K. Kim, I. Jutooru, G. Chadalapaka, G. Johnson, J. Frank, R. Burghardt, S. Kim and S. Safe: HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene, 32(13), 1616-25 (2013)

  • [24]A. Zhang, M. Xu and Y. Y. Mo: Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol, 6(3), 181-91 (2014)

  • [25]R. Maruyama, M. Shipitsin, S. Choudhury, Z. Wu, A. Protopopov, J. Yao, P. K. Lo, M. Bessarabova, A. Ishkin, Y. Nikolsky, X. S. Liu, S. Sukumar and K. Polyak: Altered antisense-to-sense transcript ratios in breast cancer. Proc Natl Acad Sci U S A, 109(8), 2820-4 (2012)

  • [26]J. Liz and M. Esteller: lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta, 1859(1), 169-76 (2016)

  • [27]P. S. Moore and Y. Chang: Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer, 10(12), 878-89 (2010)

  • [28]M. Plummer, C. de Martel, J. Vignat, J. Ferlay, F. Bray and S. Franceschi: Global burden of cancers attributable to infections in 2012: a synthetic analysis. The Lancet Global Health, 4(9), e609-e616 (2016)

  • [29]R. M. Peek, Jr. and M. J. Blaser: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer, 2(1), 28-37 (2002)

  • [30]K. T. Tycowski, Y. E. Guo, N. Lee, W. N. Moss, T. K. Vallery, M. Xie and J. A. Steitz: Viral noncoding RNAs: more surprises. Genes Dev, 29(6), 567-84 (2015)

  • [31]D. Hanahan and R. A. Weinberg: The hallmarks of cancer. Cell, 100(1), 57-70 (2000)

  • [32]D. Hanahan and R. A. Weinberg: Hallmarks of cancer: the next generation. Cell, 144(5), 646-74 (2011)

  • [33]S. Barth, T. Pfuhl, A. Mamiani, C. Ehses, K. Roemer, E. Kremmer, C. Jaker, J. Hock, G. Meister and F. A. Grasser: Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res, 36(2), 666-75 (2008)

  • [34]E. Y. Choy, K. L. Siu, K. H. Kok, R. W. Lung, C. M. Tsang, K. F. To, D. L. Kwong, S. W. Tsao and D. Y. Jin: An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med, 205(11), 2551-60 (2008)

  • [35]A. R. Marquitz, A. Mathur, C. S. Nam and N. Raab-Traub: The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology, 412(2), 392-400 (2011)

  • [36]R. L. Skalsky, D. L. Corcoran, E. Gottwein, C. L. Frank, D. Kang, M. Hafner, J. D. Nusbaum, R. Feederle, H. J. Delecluse, M. A. Luftig, T. Tuschl, U. Ohler and B. R. Cullen: The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog, 8(1), e1002484 (2012)

  • [37]L. Dolken, G. Malterer, F. Erhard, S. Kothe, C. C. Friedel, G. Suffert, L. Marcinowski, N. Motsch, S. Barth, M. Beitzinger, D. Lieber, S. M. Bailer, R. Hoffmann, Z. Ruzsics, E. Kremmer, S. Pfeffer, R. Zimmer, U. H. Koszinowski, F. Grasser, G. Meister and J. Haas: Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe, 7(4), 324-34 (2010)

  • [38]A. Hannigan, A. M. Qureshi, C. Nixon, P. M. Tsimbouri, S. Jones, A. W. Philbey and J. B. Wilson: Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Mol Cancer, 10(1), 11 (2011)

  • [39]J. Vilcek and T. H. Lee: Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem, 266(12), 7313-6 (1991)

  • [40]M. Karin and F. R. Greten: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol, 5(10), 749-59 (2005)

  • [41]L. M. Coussens and Z. Werb: Inflammation and cancer. Nature, 420(6917), 860-7 (2002)

  • [42]Z. Sun, S. Wang and R. C. Zhao: The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol, 7, 14 (2014)

  • [43]S. Landi, V. Moreno, L. Gioia-Patricola, E. Guino, M. Navarro, J. de Oca, G. Capella, F. Canzian and G. Bellvitge Colorectal Cancer Study: Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res, 63(13), 3560-6 (2003)

  • [44]R. H. Edwards, A. R. Marquitz and N. Raab-Traub: Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol, 82(18), 9094-106 (2008)

  • [45]A. Grundhoff, C. S. Sullivan and D. Ganem: A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA, 12(5), 733-50 (2006)

  • [46]R. P. Kincaid and C. S. Sullivan: Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog, 8(12), e1003018 (2012)

  • [47]T. Xia, A. O'Hara, I. Araujo, J. Barreto, E. Carvalho, J. B. Sapucaia, J. C. Ramos, E. Luz, C. Pedroso, M. Manrique, N. L. Toomey, C. Brites, D. P. Dittmer and W. J. Harrington, Jr.: EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res, 68(5), 1436-42 (2008)

  • [48]H. L. Ploegh: Viral strategies of immune evasion. Science, 280(5361), 248-53 (1998)

  • [49]M. R. Ambrosio, M. Navari, L. Di Lisio, E. A. Leon, A. Onnis, S. Gazaneo, L. Mundo, C. Ulivieri, G. Gomez, S. Lazzi, M. A. Piris, L. Leoncini and G. De Falco: The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infect Agent Cancer, 9, 12 (2014)

  • [50]E. Seto, A. Moosmann, S. Gromminger, N. Walz, A. Grundhoff and W. Hammerschmidt: Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog, 6(8), e1001063 (2010)

  • [51]H. Iizasa, B. E. Wulff, N. R. Alla, M. Maragkakis, M. Megraw, A. Hatzigeorgiou, D. Iwakiri, K. Takada, A. Wiedmer, L. Showe, P. Lieberman and K. Nishikura: Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem, 285(43), 33358-70 (2010)

  • [52]M. Samanta, D. Iwakiri, T. Kanda, T. Imaizumi and K. Takada: EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J, 25(18), 4207-14 (2006)

  • [53]A. S. Banerjee, A. D. Pal and S. Banerjee: Epstein-Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration. Virology, 443(2), 294-305 (2013)

  • [54]T. Lei, K. S. Yuen, R. Xu, S. W. Tsao, H. Chen, M. Li, K. H. Kok and D. Y. Jin: Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Int J Cancer, 133(1), 79-87 (2013)

  • [55]J. W. Pollard: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer, 4(1), 71-8 (2004)

  • [56]J. Condeelis and J. W. Pollard: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell, 124(2), 263-6 (2006)

  • [57]J. Wyckoff, W. Wang, E. Y. Lin, Y. Wang, F. Pixley, E. R. Stanley, T. Graf, J. W. Pollard, J. Segall and J. Condeelis: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res, 64(19), 7022-9 (2004)

  • [58]H. Yamaguchi, F. Pixley and J. Condeelis: Invadopodia and podosomes in tumor invasion. Eur J Cell Biol, 85(3-4), 213-8 (2006)

  • [59]C. Murdoch, A. Giannoudis and C. E. Lewis: Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood, 104(8), 2224-34 (2004)

  • [60]Y. Yang, M. Sun, L. Wang and B. Jiao: HIFs, angiogenesis, and cancer. J Cell Biochem, 114(5), 967-74 (2013)

  • [61]C. Y. Hsu, Y. H. Yi, K. P. Chang, Y. S. Chang, S. J. Chen and H. C. Chen: The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog, 10(2), e1003974 (2014)

  • [62]T. Kanda, M. Miyata, M. Kano, S. Kondo, T. Yoshizaki and H. Iizasa: Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. J Virol, 89(5), 2684-97 (2015)

  • [63]Z. Chen, D. Zhang, F. Yue, M. Zheng, Z. Kovacevic and D. R. Richardson: The iron chelators Dp44mT and DFO inhibit TGF-beta-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem, 287(21), 17016-28 (2012)

  • [64]R. Jin, W. Liu, S. Menezes, F. Yue, M. Zheng, Z. Kovacevic and D. R. Richardson: The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of beta-catenin through mechanisms involving FRAT1 and PAK4. J Cell Sci, 127(Pt 14), 3116-30 (2014)

  • [65]B. R. Cullen: Viruses and microRNAs. Nat Genet, 38 Suppl, S25-30 (2006)

  • [66]E. Gottwein and B. R. Cullen: Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe, 3(6), 375-87 (2008)

  • [67]J. R. Abend, D. Ramalingam, P. Kieffer-Kwon, T. S. Uldrick, R. Yarchoan and J. M. Ziegelbauer: Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J Virol, 86(21), 11663-74 (2012)

  • [68]D. Liang, Y. Gao, X. Lin, Z. He, Q. Zhao, Q. Deng and K. Lan: A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Res, 21(5), 793-806 (2011)

  • [69]J. M. Ziegelbauer, C. S. Sullivan and D. Ganem: Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet, 41(1), 130-4 (2009)

  • [70]J. R. Abend, T. Uldrick and J. M. Ziegelbauer: Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol, 84(23), 12139-51 (2010)

  • [71]G. Suffert, G. Malterer, J. Hausser, J. Viiliainen, A. Fender, M. Contrant, T. Ivacevic, V. Benes, F. Gros, O. Voinnet, M. Zavolan, P. M. Ojala, J. G. Haas and S. Pfeffer: Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS Pathog, 7(12), e1002405 (2011)

  • [72]R. L. Skalsky, M. A. Samols, K. B. Plaisance, I. W. Boss, A. Riva, M. C. Lopez, H. V. Baker and R. Renne: Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol, 81(23), 12836-45 (2007)

  • [73]X. Lei, Z. Bai, F. Ye, J. Xie, C. G. Kim, Y. Huang and S. J. Gao: Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol, 12(2), 193-9 (2010)

  • [74]F. Lu, W. Stedman, M. Yousef, R. Renne and P. M. Lieberman: Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol, 84(6), 2697-706 (2010)

  • [75]X. Lin, D. Liang, Z. He, Q. Deng, E. S. Robertson and K. Lan: miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS One, 6(1), e16224 (2011)

  • [76]Z. Qin, P. Kearney, K. Plaisance and C. H. Parsons: Pivotal Advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. Journal of Leukocyte Biology, 87(1), 25-34 (2009)

  • [77]E. Gottwein and B. R. Cullen: A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol, 84(10), 5229-37 (2010)

  • [78]M. A. Samols, R. L. Skalsky, A. M. Maldonado, A. Riva, M. C. Lopez, H. V. Baker and R. Renne: Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog, 3(5), e65 (2007)

  • [79]M. Hu, C. Wang, W. Li, W. Lu, Z. Bai, D. Qin, Q. Yan, J. Zhu, B. J. Krueger, R. Renne, S. J. Gao and C. Lu: A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling. PLoS Pathog, 11(9), e1005171 (2015)

  • [80]Y. J. Xie, Z. F. Long and X. S. He: Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis. Asian Pac J Cancer Prev, 14(10), 5637-44 (2013)

  • [81]A. K. Lo, C. W. Dawson, D. Y. Jin and K. W. Lo: The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol, 227(4), 392-403 (2012)

  • [82]K. Qian, T. Pietila, M. Ronty, F. Michon, M. J. Frilander, J. Ritari, J. Tarkkanen, L. Paulin, P. Auvinen and E. Auvinen: Identification and validation of human papillomavirus encoded microRNAs. PLoS One, 8(7), e70202 (2013)

  • [83]L. Rymo: Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells. J Virol, 32(1), 8-18 (1979)

  • [84]M. D. Rosa, E. Gottlieb, M. R. Lerner and J. A. Steitz: Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol, 1(9), 785-96 (1981)

  • [85]J. Komano, S. Maruo, K. Kurozumi, T. Oda and K. Takada: Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol, 73(12), 9827-31 (1999)

  • [86]S. A. McKenna, D. A. Lindhout, T. Shimoike, C. E. Aitken and J. D. Puglisi: Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR. J Mol Biol, 372(1), 103-13 (2007)

  • [87]W. Ahmed and G. Khan: The labyrinth of interactions of Epstein-Barr virus-encoded small RNAs. Rev Med Virol, 24(1), 3-14 (2014)

  • [88]A. Giudice, G. D'Arena, A. Crispo, M. F. Tecce, F. Nocerino, M. Grimaldi, E. Rotondo, A. M. D'Ursi, M. Scrima, M. Galdiero, G. Ciliberto, M. Capunzo, G. Franci, A. Barbieri, S. Bimonte and M. Montella: Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis. Oxid Med Cell Longev, 2016, 6021934 (2016)

  • [89]D. Iwakiri, L. Zhou, M. Samanta, M. Matsumoto, T. Ebihara, T. Seya, S. Imai, M. Fujieda, K. Kawa and K. Takada: Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med, 206(10), 2091-9 (2009)

  • [90]A. Nanbo, K. Inoue, K. Adachi-Takasawa and K. Takada: Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J, 21(5), 954-65 (2002)

  • [91]N. Kitagawa, M. Goto, K. Kurozumi, S. Maruo, M. Fukayama, T. Naoe, M. Yasukawa, K. Hino, T. Suzuki, S. Todo and K. Takada: Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J, 19(24), 6742-50 (2000)

  • [92]S. Alas, C. Emmanouilides and B. Bonavida: Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. Clin Cancer Res, 7(3), 709-23 (2001)

  • [93]L. Zeng, C. O'Connor, J. Zhang, A. M. Kaplan and D. A. Cohen: IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines. Cytokine, 49(3), 294-302 (2010)

  • [94]B. Sredni, M. Weil, G. Khomenok, I. Lebenthal, S. Teitz, Y. Mardor, Z. Ram, A. Orenstein, A. Kershenovich, S. Michowiz, Y. I. Cohen, Z. H. Rappaport, I. Freidkin, M. Albeck, D. L. Longo and Y. Kalechman: Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res, 64(5), 1843-52 (2004)

  • [95]A. Shinozaki, T. Sakatani, T. Ushiku, R. Hino, M. Isogai, S. Ishikawa, H. Uozaki, K. Takada and M. Fukayama: Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res, 70(11), 4719-27 (2010)

  • [96]T. Kimura, S. Jiang, N. Yoshida, R. Sakamoto and M. Nishizawa: Interferon-alpha competing endogenous RNA network antagonizes microRNA-1270. Cell Mol Life Sci, 72(14), 2749-61 (2015)

  • [97]M. Nishizawa and T. Kimura: RNA Networks that Regulate mRNA Expression and their Potential as Drug Targets. RNA & DISEASE, 3, e864 (2016)

  • [98]R. Sun, S. F. Lin, L. Gradoville and G. Miller: Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A, 93(21), 11883-8 (1996)

  • [99]W. Zhong and D. Ganem: Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol, 71(2), 1207-12 (1997)

  • [100]S. Borah, N. Darricarrere, A. Darnell, J. Myoung and J. A. Steitz: A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression. PLoS Pathog, 7(10), e1002300 (2011)

  • [101]C. C. Rossetto and G. S. Pari: Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation. J Virol, 85(24), 13290-7 (2011)

  • [102]C. C. Rossetto, M. Tarrant-Elorza, S. Verma, P. Purushothaman and G. S. Pari: Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA. J Virol, 87(10), 5540-53 (2013)

  • [103]G. Franchini: Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood, 86(10), 3619-39 (1995)

  • [104]G. Gaudray, F. Gachon, J. Basbous, M. Biard-Piechaczyk, C. Devaux and J. M. Mesnard: The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol, 76(24), 12813-22 (2002)

  • [105]Y. Mitobe, J. Yasunaga, R. Furuta and M. Matsuoka: HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival. Cancer Res, 75(19), 4143-52 (2015)

  • [106]Y. Satou, J. Yasunaga, M. Yoshida and M. Matsuoka: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A, 103(3), 720-5 (2006)

  • [107]M. J. Blaser, G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann and A. Nomura: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res, 55(10), 2111-5 (1995)

  • [108]J. Parsonnet, G. D. Friedman, N. Orentreich and H. Vogelman: Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40(3), 297-301 (1997)

  • [109]J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. M. Parkin, D. Forman and F. Bray: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136(5), E359-86 (2015)

  • [110]M. Plummer, S. Franceschi, J. Vignat, D. Forman and C. de Martel: Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer, 136(2), 487-90 (2015)

  • [111]M. Hatakeyama: Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer, 4(9), 688-94 (2004)

  • [112]Z. Z. Chong and K. Maiese: The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol, 22(11), 1251-67 (2007)

  • [113]P. Saju, N. Murata-Kamiya, T. Hayashi, Y. Senda, L. Nagase, S. Noda, K. Matsusaka, S. Funata, A. Kunita, M. Urabe, Y. Seto, M. Fukayama, A. Kaneda and M. Hatakeyama: Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein–Barr virus. Nature Microbiology, 1 (2016)

  • [114]S. Akiba, C. Koriyama, R. Herrera-Goepfert and Y. Eizuru: Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci, 99(2), 195-201 (2008)

  • [115]M. V. Lin, L. Y. King and R. T. Chung: Hepatitis C virus-associated cancer. Annu Rev Pathol, 10, 345-70 (2015)

  • [116]Z. Wang, K. Ceniccola, L. Florea, B. D. Wang, N. H. Lee and A. Kumar: Viral non-coding RNA inhibits HNF4alpha expression in HCV associated hepatocellular carcinoma. Infect Agent Cancer, 10, 19 (2015)

  • [117]S. Thuault, E. J. Tan, H. Peinado, A. Cano, C. H. Heldin and A. Moustakas: HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem, 283(48), 33437-46 (2008)

  • [118]S. Lamouille, J. Xu and R. Derynck: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol, 15(3), 178-96 (2014)

  • [119]W. Bao, L. Florea, N. Wu, Z. Wang, K. Banaudha, J. Qian, L. Houzet, R. Kumar and A. Kumar: Loss of nuclear PTEN in HCV-infected human hepatocytes. Infect Agent Cancer, 9, 23 (2014)

  • [120]W. H. Shen, A. S. Balajee, J. Wang, H. Wu, C. Eng, P. P. Pandolfi and Y. Yin: Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell, 128(1), 157-70 (2007)

  • [121]P. G. Smiraldo, A. M. Gruver, J. C. Osborn and D. L. Pittman: Extensive chromosomal instability in Rad51d-deficient mouse cells. Cancer Res, 65(6), 2089-96 (2005)

  • [122]D. Kremsdorf, P. Soussan, P. Paterlini-Brechot and C. Brechot: Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene, 25(27), 3823-33 (2006)

  • [123]M. A. Feitelson and J. Lee: Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett, 252(2), 157-70 (2007)

  • [124]M. Levrero: Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene, 25(27), 3834-47 (2006)

  • [125]A. Saha and E. S. Robertson: Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res, 17(10), 3056-63 (2011)

  • [126]Y. Chang, E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles and P. S. Moore: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266(5192), 1865-9 (1994)

  • [127]D. Martin and J. S. Gutkind: Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene, 27 Suppl 2, S31-42 (2008)

  • [128]M. A. Whiteside, E. M. Siegel and E. R. Unger: Human papillomavirus and molecular considerations for cancer risk. Cancer, 113(10 Suppl), 2981-94 (2008)

  • [129]K. Takatsuki: Discovery of adult T-cell leukemia. Retrovirology, 2, 16 (2005)

  • [130]N. Uemura, S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. Taniyama, N. Sasaki and R. J. Schlemper: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 345(11), 784-9 (2001)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Mar 2017Review

Pathogen-associated regulatory non-coding RNAs and oncogenesis

Noriyuki Yoshida 1, Tominori Kimura 1,*
Affiliation
Article Info

1 Laboratory of Microbiology and Cell Biology, Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Noji-Higashi, Kusatsu, Shiga 525-8577, Japan

Abstract

Among all new cancer cases in 2012, on average, 15.4% were caused by Helicobacter pylori or oncoviruses, including Epstein-Barr virus, human papillomavirus, hepatitis B virus, hepatitis C viruses, Kaposi sarcoma-associated herpesvirus and human T-lymphotropic virus. These pathogens encode a variety of non-coding RNAs, which are important cofactors for oncogenesis. In this review, we focus on recent developments in the study of long and small non-protein-coding RNAs, including microRNAs, of oncogenic pathogens, and discuss their mechanisms of action in the multiple steps of oncogenesis.

Keywords

  • Regulatory non-coding RNA
  • Oncogenesis
  • microRNA
  • Small ncRNA
  • Long ncRNA
  • Cancer hallmarks
  • Review

References